Findings could help in the development of treatments to prevent brain inflammation associated with Alzheimer's disease.
CRISPR technology allows researchers to illuminate and monitor alpha synuclein in the brain.
Older adults who are physically active have greater gray matter volume and a decreased risk of Alzheimer's disease, a new study reports.
